Meanwhile, cash-strapped biotechs have in many cases been forced to leverage relationships with big pharma to address liquidity. Cash is king in a financing environment such as we have observed over the last 18 months, and...more
12/22/2023
/ Borrowers ,
Capital Markets ,
EBITDA ,
Environmental Social & Governance (ESG) ,
EU ,
Financing ,
Healthcare ,
Investment ,
Lenders ,
Life Sciences ,
Secondary Credit Markets ,
Technology Sector ,
Venture Capital
We can't wait to see you in Paris at our second annual symposium. You'll meet with senior executives in the health, life sciences and private equity industries to identify new investment opportunities and position your...more
10/19/2023
/ Artificial Intelligence ,
Events ,
Financing ,
Health Care Providers ,
Health Information Technologies ,
Healthcare Facilities ,
Investment Opportunities ,
Investors ,
Life Sciences ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds
Past: Once Upon a Time -
Thinking back to pre-pandemic times, it cannot be said that the Italian private equity (PE) and venture capital (VC) market was particularly flourishing or on the rise. Funding was decreasing...more
On 11 June 2021, the German Federal Parliament approved the draft bill on corporate due diligence in supply chains (Supply Chain Due Diligence Act), which was approved by the German Federal Council without any changes on 25...more
7/13/2021
/ Acquisitions ,
Annual Reports ,
Competent Authority (CA) ,
Due Diligence ,
Duty of Care ,
Environmental Social & Governance (ESG) ,
EU ,
France ,
Germany ,
Human Rights ,
Italy ,
Liability ,
Mergers ,
Modern Slavery Act ,
New Legislation ,
Risk Management ,
Sanctions ,
Supply Chain ,
Sustainability ,
UK ,
United States ,
Whistleblowers
Privacy Shield Implementation and How-To Kit from McDermott Will & Emery -
Japanese companies may have European branches or subsidiaries that send personal data to the US or that may be accessed by entities in the US,...more